Cite Filings / STOK / 0001950047-25-007743

Feed Companies Filings Check

Sign in

144

Sale of Securities

Stoke Therapeutics, Inc. Filed 2025-10-03 Acc 0001950047-25-007743

Documents 1

144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

2025-10-08 144 Sale of Securities
2025-10-07 4 Director sold 42,461 shares at $25.09 ($1,065,206)
2025-10-06 8-K Executive or director change
2025-10-03 144 Sale of Securities
2025-10-03 144 Sale of Securities
2025-10-03 4 CHIEF MEDICAL OFFICER sold 5,343 shares at $23.64 ($126,316)
2025-10-01 4 Director acquired 1,211 shares (option exercise)

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…